These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3081778)

  • 1. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.
    Vague P; Juhan-Vague I; Aillaud MF; Badier C; Viard R; Alessi MC; Collen D
    Metabolism; 1986 Mar; 35(3):250-3. PubMed ID: 3081778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C
    Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
    Auwerx J; Bouillon R; Collen D; Geboers J
    Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.
    Vague P; Juhan-Vague I; Alessi MC; Badier C; Valadier J
    Thromb Haemost; 1987 Jun; 57(3):326-8. PubMed ID: 3310318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
    Mehta J; Mehta P; Lawson D; Saldeen T
    J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
    Takada A; Takada Y; Urano T; Sakakibara K; Rydzewski A
    Thromb Res; 1990 Jan; 57(1):13-20. PubMed ID: 2105539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin.
    Stegnar M; Pentek M
    Thromb Res; 1993 Jan; 69(1):81-92. PubMed ID: 8465277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
    Haire WD; Goldsmith JC; Rasmussen J
    Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
    Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
    Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
    Juhan-Vague I; Alessi MC; Joly P; Thirion X; Vague P; Declerck PJ; Serradimigni A; Collen D
    Arteriosclerosis; 1989; 9(3):362-7. PubMed ID: 2470343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.
    De Mitrio V; De Pergola G; Vettor R; Marino R; Sciaraffia M; Pagano C; Scaraggi FA; Di Lorenzo L; Giorgino R
    Metabolism; 1999 Aug; 48(8):960-4. PubMed ID: 10459558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction.
    Calles-Escandon J; Ballor D; Harvey-Berino J; Ades P; Tracy R; Sobel B
    Am J Clin Nutr; 1996 Jul; 64(1):7-11. PubMed ID: 8669417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
    Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
    Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.